Diagnostic Kits/Paper: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
No edit summary
No edit summary
Line 22: Line 22:
== Our Methodology ==
== Our Methodology ==


=== Literature Review ===


=== Key Interviews ===
=== Disruptive Innovation Framework ===




== Forces affecting the EM Industry ==
== Forces affecting the EM Industry ==


=== Technological Innovations in EM ===
=== Consumer Advocacy Campaigns ===


=== Relevant Public Policy ===


   
   
== Existing and Evolving EM and OER Models ==
== Existing and Evolving EM and OER Models ==


=== Teacher-centric versus Student-centric ===
=== For-profit versus Non-profit ===


=== Hybrid Models ===




== Discussion ==
== Discussion ==


=== Need for Open Access ===
=== Need for Participation ===


=== Significance of OER Movement ===




Revision as of 12:28, 3 December 2009

Are patents clogging the pipeline: The effects of intellectual property on commercialization and access to genetic diagnostics
(A Summary Paper of our Research to date)
By Carolina Rossini, Andrew Clearwater, and Mackenzie Cowell

Last Draft: December 3, 2009

Introduction

Description of the GDx Market

Defining Genetic Diagnostics

from Educational_Materials#Field_Definition

Brief History of EM and Related Technology

Overview of IP Landscape

Our Research Questions

Our Methodology

Forces affecting the EM Industry

Existing and Evolving EM and OER Models

Discussion

Conclusions

Bibliography

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Diagnostic_Kits/Paper&oldid=5561"